Pictor
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5315 Avenida Encinas Ste 120, Carlsbad, ...Phone Number
(800) 641-1096Website
www.pictordx.comRevenue
$9.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Pictor
Pictor Holdings Inc. is a global proteomics company headquartered in Carlsbad, California, with laboratory and commercial operations across New Zealand, Australia, and India. The company develops targeted multi-analyte proteomic assay solutions for human and animal health research, enabling laboratories and biopharmaceutical partners to conduct efficient, high-throughput protein analysis. Its technology platform is designed to support research, biomarker discovery, and diagnostic development through scalable and cost-effective proteomic testing, supported by a strong portfolio of intellectual property and proprietary technologies.Explore more
Pictor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pictor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pictor had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Pictor has new funding data
Product Launch: Get notified when Pictor launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Pictor recently announced quarterly report
Pictor, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Pictor
Check if Pictor has recently received funding, and reach out quickly before it becomes old news!
Check out if Pictor is spiking on competitors!
Recommended Actions
Find VP level buyers at Pictor
Find 3 more new buyers
Company Profile Activity
Activity Insights
Pictor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pictor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pictor.
Pictor financials insights
Gather financial insights about Pictor, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Unspecified
$6.1M
2026
Private Equity
$7.5M
Pictor Tech Stack
A closer look at the technologies used by Pictor
Most Recent Scoops
Person-Based
Product Launch
Person-Based
Medical Research
Person-Based
Partnership, Medical Research
Person-Based
Partnership, Product Development, Medical Research
Person-Based
Medical Research
Pictor News & Media
Pictor Receives CE Mark for its PictArray™ SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster
LOS ANGELES--(BUSINESS WIRE)--Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its PictArray™ SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test as per In Vitro Diagnostic Directive (IVDD) regulations. The CE Mark will allow the company to market its COVID-19 antibody test in Europe and gain regulatory approval in Southeast Asia. “Receiving CE registration enabBiotech Firm Tackling COVID-19 and M. bovis Announces Successful Development of Rapid, Accurate Johne’s Disease Assay
LOS ANGELES--(BUSINESS WIRE)--Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) – also known as Johne’s disease, that could save the New Zealand dairy industry upwards of $80 million a year in lost production. “The PictArray™ MAP assay would be a positive addition to national control programs to help in the eradication of Johne’s disease from the dairy industry,” says Pictor’Pictor Successfully Completes Validation Trial in U.S. for its...
The Pictor test simultaneously detects the presence of both anti-Spike (SP) antibody and anti-Nucleocapsid (NP) antibody in a single test. (PRWeb January 20, 2022) Read the full story at https://www.prweb.com/releases/pictor_successfully_completes_validation_trial_in_u_s_for_its_sars_co_v_2_antibody_test/prweb18430082.htmPictArray™ COVID-19 Antibody Test: Demonstrates High Clinical...
Antibody Test from Pictor begins clinical trials; soon to secure FDA Emergency Use Authorization (PRWeb March 25, 2021) Read the full story at https://www.prweb.com/releases/pictarray_covid_19_antibody_test_demonstrates_high_clinical_performance_against_standardized_covid_19_samples/prweb17822345.htm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pictor
Sign Up For FreeTo access detailed company insights
Pictor Holdings Inc. is a global proteomics company headquartered in Carlsbad, California, with laboratory and commercial operations across New Zealand, Australia, and India. The company develops targeted multi-analyte proteomic assay solutions for human and animal health research, enabling laboratories and biopharmaceutical partners to conduct eff... Read More
